These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31418284)

  • 1. Short Communication: Extremely Severe CD4 Lymphopenia During HIV-1 Primary Infection.
    Bonnet B; Blum L; Charpentier C; Martres P; Ritvo PG; Autran B; Guihot A
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):930-933. PubMed ID: 31418284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of cytomegalovirus-specific CD4 T cells in HIV-1-infected individuals receiving antiretroviral therapy.
    Grosse V; Schulte A; Weber K; Mendila M; Jacobs R; Schmidt RE; Heiken H
    AIDS; 2002 May; 16(7):1075-7. PubMed ID: 11953477
    [No Abstract]   [Full Text] [Related]  

  • 3. Temporary seronegativity in a human immunodeficiency virus type 1-infected man.
    Zaaijer HL; Bloemer MH; Lelie PN
    J Med Virol; 1997 Jan; 51(1):80-2. PubMed ID: 8986953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saitoh A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Microbiol; 1995 Feb; 33(2):298-303. PubMed ID: 7714182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia.
    Al-Aska A; Al-Anazi AR; Al-Subaei SS; Al-Hedaithy MA; Barry MA; Somily AM; Buba F; Yusuf U; Al Anazi NA
    Eur J Med Res; 2011 Jun; 16(6):285-8. PubMed ID: 21810564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low CD4 count in HIV negative malaria cases and normal CD4 count in HIV positive and malaria negative patients.
    Chirenda J
    Cent Afr J Med; 1999 Sep; 45(9):248. PubMed ID: 11019476
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection.
    Haponsaph R; Darden JM; Chantakulkij S; Sannoi N; de Souza MS; Brown AE; Birx DL; Polonis VR; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2004 Mar; 22(1):39-48. PubMed ID: 15366657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
    Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
    Fleury S; Rizzardi GP; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly JY; Corpataux JM; Lazzarin A; Miedema F; Pantaleo G
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5393-8. PubMed ID: 10805798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 depletion in HIV-infected haemophilia patients is associated with rapid clearance of immune complex-coated CD4+ lymphocytes.
    Daniel V; Melk A; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Clin Exp Immunol; 1999 Mar; 115(3):477-84. PubMed ID: 10193421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of CD4+ T cells, HIV disease stage and zidovudine on HIV isolation in Bahia, Brazil.
    Brites C; Pedroso C; Silva N; Johnson WD; Badaró R
    Rev Soc Bras Med Trop; 1996; 29(1):5-9. PubMed ID: 8851208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
    Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
    AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.
    Alimonti JB; Koesters SA; Kimani J; Matu L; Wachihi C; Plummer FA; Fowke KR
    J Infect Dis; 2005 Jan; 191(1):20-4. PubMed ID: 15592998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients.
    Ayehunie S; Sönnerborg A; Desta B; Kefene H; Zewdie D; Britton S; Strannegård O
    AIDS; 1992 Jul; 6(7):651-7. PubMed ID: 1503684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
    Lafeuillade A; Tamalet C; Pellegrino P; de Micco P; Vignoli C; Quilichini R
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
    Tansiri Y; Rowland-Jones SL; Ananworanich J; Hansasuta P
    PLoS One; 2015; 10(3):e0118871. PubMed ID: 25764310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic confirmation of HIV infection.
    Chronister CL
    Optom Vis Sci; 1995 May; 72(5):299-301. PubMed ID: 7667004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.